Gracell Biotechnologies Reports Long-term Follow-up Data on TruUCAR-enabled GC027 in…
Gracell Biotechnologies Inc., a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment of cancer, presented updated long-term follow-up data on their…